A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK (Q66399711)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK |
clinical trial |
Statements
A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial to Evaluate the EBA, Safety and PK of Orally Administered LCB01-0371 in Adult Patients With Smear-positive Pulmonary Tuberculosis (English)
0 references
10 December 2016
0 references
October 2018
0 references
64
0 references
19 year
0 references
70 year
0 references